Larvol Delta - BioNTech-and-OncoC4-Present-Updated-Data-Showing-Gotistobart-Nearly-Doubled-Median-Overall-Survival-versus-StandardofCare-Chemotherapy-in-Previously-Treated-Squamous-NonSmall-Cell-Lung-Cancer-Patients

gotistobart (BNT316) - OncoC4, BioNTech

https://www.biontech.com/int/en/home/mediaroom/news/press-releases/2026/09/BioNTech-and-OncoC4-Present-Updated-Data-Showing-Gotistobart-Nearly-Doubled-Median-Overall-Survival-versus-Standard-of-Care-Chemotherapy-in-Previously-Treated-Squamous-Non-Small-Cell-Lung-Cancer-Patients.html

Sep 14, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next